A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)

Clinical trial NCT00495287 · COMPLETED

Trial details

NCT number: NCT00495287
Sponsor: Northern Italy Leukemia Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2006-11-01
Primary completion: 2015-07-01
Enrollment: 573

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.